Dr. Joseph M. Chalil, Novo Integrated Sciences’ Chief Medical Officer, Selected As Top Physician Of The Year By IAOTP

Dr. Joseph M. Chalil, MD, MBA, FACHE, Chief Medical Officer of Novo Integrated Sciences, Inc. (Novo). Global Healthcare Executive and Best-Selling Author, has been selected as Top Physician of the Year for 2022 by the International Association of Top Professionals (IAOTP) for his outstanding leadership, dedication, and innovative medical contributions.

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) , pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for services and product innovation, made the announcement last week

While inclusion with the International Association of Top Professionals is an honor in itself, only a few members in each discipline are chosen for this distinction. These special honorees are distinguished based on their professional accomplishments, academic achievements, leadership abilities, other affiliations, and contributions to their communities. All honorees are invited to attend the IAOTP’s annual awards gala at the end of this year for a night to honor their achievements.

Stephanie Cirami, IAOTP President, stated, “We are honored to have Dr. Chalil as part of our IAOTP family. He is brilliant at what he does, has a unique understanding of health policies, and a diverse medical background. We know he will be an amazing asset to our network of professionals.”

Dr. Chalil has over 20 years of professional experience in health policy, medical affairs, and clinical development with an emphasis on both healthcare delivery and biotechnology. Previously, Dr. Chalil has held roles of increasing responsibility at DBV Technologies, Boehringer Ingelheim, Abbott Laboratories, and Hoffmann-La Roche. Dr. Chalil was the honored recipient of the AAPI Presidential Award (2015) and the Boehringer President’s Club Award for 2011, 2014, and 2015. Dr. Chalil was also recognized and honored with the 2013 Outstanding 50 Asian Americans in Business Award.

Dr. Chalil is an author of several scientific and research papers in international publications. He is also the Chairman of the Complex Health Systems Advisory Board, H. Wayne Huizenga College of Business and Entrepreneurship at Nova Southeastern University in Florida, and a member of Dr. Kiran C. Patel College of Allopathic Medicine Executive Leadership Council. A veteran of the U.S. Navy Medical Corps, he is board certified in healthcare management. He has been awarded a Fellowship by the American College of Healthcare Executives, an international professional society of more than 40,000 healthcare executives who lead hospitals, healthcare systems, and other healthcare organizations. Additionally, Dr. Chalil is the former Chairman of the Indo-American Press Club. He is an expert in U.S. healthcare policy and a strong advocate for patient-centered care. A strong proponent of providing healthcare access to everyone, Dr. Chalil’s new book, Beyond the COVID-19 Pandemic: Envisioning a Better World by Transforming the Future of Healthcare, is on Amazon’s Best Sellers List.

For more information on Dr. Chalil, please visit: https://www.linkedin.com/in/drchalil/

The International Association of Top Professionals (IAOTP) is an international boutique networking organization that handpicks the world’s finest, most prestigious top professionals from different industries. These top professionals are given an opportunity to collaborate, share their ideas, be keynote speakers, and to help influence others in their fields. This organization is not a membership that anyone can join. You must be asked by the President or be nominated by a distinguished honorary member after a brief interview.

Novo Integrated Sciences, Inc. is pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for services and product innovation. Novo offers an essential and differentiated solution to deliver, or intend to deliver, these services and products through the integration of medical technology, diagnostic and therapeutic solutions, and rehabilitative science.

The Company’s decentralized healthcare business model is centered on three primary pillars to best support the transformation of non-catastrophic healthcare delivery to patients and consumers.

Innovation through science combined with the integration of sophisticated, secure technology assures Novo Integrated Sciences of continued cutting-edge advancement in patient first platforms.

For more information concerning Novo Integrated Sciences, please visit www.novointegrated.com. For more information on Novo Healthnet Limited, Novo’s wholly owned subsidiary, please visit www.novohealthnet.com.

Leave a Reply

Your email address will not be published. Required fields are marked *

More Related Stories